Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
NMI Holdings, Inc.
NMIH·Financials
A ★★★★Buy
Current$44.30
Target$48.00
Return+8.4%
Aug 4, 2026

NMI Holdings couples structurally superior underwriting margins and aggressive buybacks to compound value, though investors must stomach inherent exposure to U.S. housing and employment macro cycles.

Score
88
Alnylam Pharmaceuticals, Inc.
ALNY·Healthcare
A ★★★★Buy
Current$205.48
Target$375.90
Return+82.9%
Aug 3, 2026

The recent 25% selloff has created a generational entry point for a dominant RNAi monopoly generating hyper-growth and massive free cash flow, despite near-term turbulence from normalizing demand in the ATTR-CM market.

Score
88
Nextpower Inc.
NXT·Technology
A ★★★★Buy
Current$100.03
Target$135.00
Return+35.0%
Aug 2, 2026

Nextpower’s unmatched bankability and asset-light cash generation make it the dominant beneficiary of the solar supercycle, though the looming expiration of U.S. tax credits poses a long-term demand headwind.

Score
88
Tradeweb Markets Inc.
TW·Financials
A ★★★★Buy
Current$97.80
Target$129.00
Return+31.9%
Aug 1, 2026

Tradeweb's structural market share gains in electronic fixed-income trading promise secular growth, though near-term revenue misses and LSEG's majority voting control warrant careful multiple monitoring.

Score
88
Banco de Chile
BCH·Financials
A ★★★★Buy
Current$40.72
Target$45.60
Return+12.0%
Aug 1, 2026

Banco de Chile is an elite compounding machine protected by a low-cost deposit monopoly and fortress capital, though its volume growth remains heavily tethered to a sluggish Chilean macroeconomic recovery and normalizing inflation.

Score
88
S&P Global Inc.
SPGI·Financials
A ★★★★Buy
Current$419.64
Target$519.20
Return+23.7%
Jul 31, 2026

S&P Global offers unparalleled, high-margin exposure to global capital market expansion and passive investing inflows, though investors must monitor the risk of AI-driven headcount reductions eroding its terminal-subscription base.

Score
88
Centene Corporation
CNC·Healthcare
A ★★★★Buy
Current$60.84
Target$76.80
Return+26.2%
Jul 31, 2026

Centene offers a deep-value, massive cash-generating turnaround play driven by confirmed 2026 structural margin repair, constrained solely by the looming political threat of ACA subsidy expirations.

Score
88
HNI Corporation
HNI·Industrials
A ★★★★Buy
Current$44.10
Target$65.00
Return+47.4%
Jul 30, 2026

HNI's transformative $1.9 billion acquisition of Steelcase offers massive synergy potential and deep undervaluation, though integration execution risks require careful monitoring alongside macro housing headwinds.

Score
88
AXIS Capital Holdings Limited
AXS·Financials
A ★★★★Buy
Current$119.27
Target$135.00
Return+13.2%
Jul 30, 2026

AXIS Capital represents a deeply undervalued, brilliantly de-risked specialty insurance compounder supported by aggressive share buybacks, but near-term upside is heavily constrained by cyclical rate softening and severe property catastrophe volatility.

Score
88
Western Alliance Bancorporation
WAL·Financials
A ★★★★Buy
Current$83.65
Target$112.50
Return+34.5%
Jul 29, 2026

Western Alliance is a fundamentally undervalued, high-ROATCE compounding machine perfectly positioned to squeeze massive operating leverage from its low-cost deposit franchise, provided it can successfully navigate impending commercial real estate headwinds and the regulatory gauntlet of the $100 billion asset threshold.

Score
88
COPT Defense Properties
CDP·Real Estate
A ★★★★Buy
Current$38.03
Target$44.02
Return+15.8%
Jul 29, 2026

COPT Defense offers an impenetrable real estate monopoly deeply embedded in the U.S. defense apparatus, positioned for structural growth through cyber and intelligence spending, though extreme reliance on federal budgets poses long-term concentration risk.

Score
88
First Industrial Realty Trust, Inc.
FR·Real Estate
A ★★★★Buy
Current$66.99
Target$78.00
Return+16.4%
Jul 29, 2026

First Industrial offers a premier, supply-constrained logistics portfolio generating massive 39% rent spreads and hidden data center land value, though near-term occupancy dips require careful execution of its Q4 development lease-up pipeline.

Score
88
FactSet Research Systems Inc.
FDS·Financials
A ★★★★Buy
Current$283.87
Target$440.25
Return+55.1%
Jul 29, 2026

FactSet offers immense upside driven by accelerating organic growth, a massive $1B buyback, and an aggressive new CEO executing a wealth management pivot, provided the company can successfully defend its operating margins against the rising costs of AI infrastructure and the threat of low-cost data commoditization.

Score
88
Invesco Ltd.
IVZ·Financials
A ★★★★Buy
Current$29.93
Target$40.60
Return+35.6%
Jul 29, 2026

Invesco offers massive operating leverage and severe undervaluation as its passive ETF franchise booms, though persistent active equity outflows remain a structural headwind.

Score
88
Graco Inc.
GGG·Industrials
A ★★★★Buy
Current$79.50
Target$96.00
Return+20.8%
Jul 27, 2026

A dominant, capital-light fluid handling monopoly with >20% ROIC and elite M&A execution, though near-term organic upside may be restrained by sluggish cyclical construction markets.

Score
88
SEI Investments Company
SEIC·Financials
A ★★★★Buy
Current$99.22
Target$121.68
Return+22.6%
Jul 27, 2026

SEI Investments offers a compelling Quality Compounder thesis driven by the secular trend of wealth management outsourcing, expanding operating margins, and a dominant scale of $1.9 trillion in assets, though traditional mutual fund outflows remain a structural headwind.

Score
88
Dover Corporation
DOV·Industrials
A ★★★★Buy
Current$202.20
Target$238.29
Return+17.8%
Jul 26, 2026

Dover is an elite industrial compounder trading at a massive peer discount, riding AI and clean energy tailwinds while managing temporary localized plant consolidation friction.

Score
88
East West Bancorp, Inc.
EWBC·Financials
A ★★★★Buy
Current$131.60
Target$155.00
Return+17.8%
Jul 24, 2026

East West Bancorp leverages its unique US-Asia cross-border niche and exceptional deposit franchise to generate industry-leading ROTCE and margin expansion, though commercial real estate exposure warrants monitoring.

Score
88
Prologis, Inc.
PLD·Real Estate
A ★★★★Buy
Current$150.06
Target$175.28
Return+16.8%
Jul 17, 2026

Prologis brilliantly combines the impenetrable, inflation-resistant moat of global logistics real estate with the explosive, high-margin upside of a $15 billion AI data center pipeline, heavily outweighing short-term M&A integration and macroeconomic interest rate risks.

Score
88
Signet Jewelers Limited
SIG·Consumer Discretionary
A ★★★★Buy
Current$99.30
Target$142.67
Return+43.7%
Sep 15, 2026

Signet Jewelers combines a deeply discounted valuation, strong cash generation, rising earnings guidance and aggressive buybacks, but the thesis remains exposed to holiday concentration, precious-metal inflation and the need to sustain positive comparable sales in a cautious consumer environment.

Score
87
ABM Industries Incorporated
ABM·Industrials
A ★★★★Buy
Current$49.43
Target$55.15
Return+11.6%
Sep 13, 2026

ABM combines resilient outsourced-facility demand, accelerating high-value semiconductor and technical-services exposure, strong cash conversion, and a discounted valuation, though its thin margins, labor intensity, and acquisition-related leverage keep execution risk meaningfully above that of a classic high-ROIC compounder.

Score
87
Abercrombie & Fitch Co.
ANF·Consumer Discretionary
A ★★★★Buy
Current$109.96
Target$128.00
Return+16.4%
Aug 26, 2026

Abercrombie & Fitch has masterfully engineered an elite, high-margin retail turnaround that the market still prices as a stagnant cyclical asset, though investors must closely monitor impending tariff pressures and the stagnation of its teenage-focused Hollister banner.

Score
87
LeMaitre Vascular, Inc.
LMAT·Healthcare
A ★★★★Buy
Current$81.86
Target$107.00
Return+30.7%
Aug 25, 2026

LeMaitre Vascular is a highly profitable, cash-rich monopoly in the niche peripheral vascular market trading at a generational valuation floor, though investors must tolerate near-term volatility from international regulatory delays and temporary manufacturing consolidation costs.

Score
87
V2X, Inc.
VVX·Industrials
A ★★★★Buy
Current$78.50
Target$102.00
Return+29.9%
Aug 25, 2026

V2X is a highly entrenched, rapidly growing defense prime trading at a deep discount that will inevitably experience massive multiple expansion as it deleverages its balance sheet, though investors must tolerate near-term volatility stemming from structural accounts receivable timing delays.

Score
87